AYER, Mass.--(BUSINESS WIRE)--Cambrooke Therapeutics Inc., an innovation leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the introduction of a kid-favorite food with its KetoVie Café Pizza Petites 3:1.
With the launch of KetoVie Café Pizza Petites 3:1, Cambrooke demonstrates its commitment to providing the very best in nutrition, variety and taste to those following the ketogenic diet for intractable epilepsy. KetoVie Café Pizza Petites 3:1 is a ready-made cheese pizza with a savory sauce and crunchy, chewy herb crust.
KetoVie Café Pizza Petites 3:1 are shipped frozen in a package of eight mini cheese pizzas. The pizzas have 2.8g of net carbs and a 3:1 ketogenic ratio. This great tasting cheese pizza cooks in fewer than 10 minutes and was designed as a snack or delicious meal.
“I am thrilled Cambrooke made this awesome keto-friendly pizza that my very picky son, who is on diet therapy, thoroughly enjoys. KetoVie Café Pizza Petites 3:1 is real pizza. It allows my son to be included in family pizza nights and to enjoy one of his favorite foods that we sadly thought we had to give up in order to succeed on diet therapy. Now being on the Ketogenic diet does not mean having to give up every kid’s favorite food,” said Kathleen Kitts.
Cambrooke Therapeutics understands the importance of patients’ needs when on a ketogenic diet. In that spirit, Cambrooke partnered again with keto chef and keto mom Dawn Martenz, author of two ketogenic diet cookbooks. Dawn was instrumental with the development of KetoVie Café Pizza Petites 3:1.
“Collaborating with Dawn, who cooks ketogenic-friendly foods every day for her daughter and understands how important ready-made foods for specialty diets are to families, has been a great addition to our Cambrooke family,” says Cambrooke Founder Lynn Paolella, who created over 100 Cambrooke low protein foods for her children with phenylketonuria.
“Ketogenic food is not always the best-tasting food, but the KetoVie Café Pizza Petites 3:1 are flavorful and satisfying,” said Kara Fox, the mother of a son with Lennox-Gastaut Syndrome who is on a special diet. “Having a product like this makes the diet much easier to handle.”
About Cambrooke Therapeutics – Founded in 2000, Cambrooke Therapeutics, Inc. is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are today focused on inborn errors of metabolism and intractable epilepsy. More information is available at www.cambrooketherapeutics.com.